Friday, 18 January 2019

AbbVie's cancer drug fails to meet main goal in late-stage study

AbbVie Inc said on Friday its cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)